Adenosine Triphosphate

Adenosine Triphosphate

SCHEMBL468214

Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 7/20 0.94
P2RX1 P51575 4/20 0.94
P2RX3 P56373 4/20 0.94
P2RY2 P41231 3/20 0.94
P2RX2 Q9UBL9 2/20 0.94
SRC P12931 2/20 0.94
SMN1; SMN2 Q16637 2/20 0.94
ALDH1A1 P00352 2/20 0.94
P2RX4 Q99571 1/20 0.94
RNASEL Q05823 1/20 0.88
TRPM2 O94759 2/20 0.88
MACROD2 A1Z1Q3 1/20 0.88
SIRT6 Q8N6T7 1/20 0.88
MACROD1 Q9BQ69 1/20 0.88
TAS1R3 Q7RTX0 2/20 0.83
TAS1R1 Q7RTX1 2/20 0.83
DNPH1 O43598 1/20 0.83
PRKAB2 O43741 1/20 0.83
LDHA P00338 1/20 0.83
ADRB2 P07550 1/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9171542 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
SCHEMBL376008 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL8979 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL12789528 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL6242713 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL18784961 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL13722152 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL13722139 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL2227081 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2
Adenosine Triphosphate SCHEMBL20550531 1.00 P2RY1 (0.94) P2RY1P2RX1P2RX3P2RY2P2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 655 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4605523-A1 OLIGONUCLEOTIDES AND METHODS FOR CAPTURING SINGLE-STRANDED TEMPLATES AND/OR TEMPLATES WITH 3' OVERHANGS Foundation Medicine, Inc. (US) 2025-08-27 EP claimed
WO-2024137316-A1 OLIGONUCLEOTIDES AND METHODS FOR CAPTURING SINGLE-STRANDED TEMPLATES AND/OR TEMPLATES WITH 3' OVERHANGS FOUNDATION MEDICINE, INC. (US) 2024-06-27 WO claimed
US-11964149-B2 Facial beautifying and care apparatus BIBOTING INTERNATIONAL CO., LTD. (TW) 2024-04-23 US claimed
US-20230225928-A1 FACIAL BEAUTIFYING AND CARE APPARATUS LIU PO CHANG (TW) 2023-07-20 US claimed
EP-4153322-A1 COUPLED TERPENE CONJUGATE Laboratoires Eriger (FR) 2023-03-29 EP claimed
WO-2022155751-A1 PRENYLATED PSILOCYBIN DERIVATIVES AND METHODS OF USING MAGICMED INDUSTRIES INC. (CA) 2022-07-28 WO claimed
US-20220032050-A1 FACIAL BEAUTIFYING AND CARE APPARATUS LIU, PO-CHANG (TW) 2022-02-03 US claimed
US-9193990-B2 Bioluminescent metal ion assay Thompson, Richard B. (US) 2015-11-24 US claimed
US-20140273038-A1 BIOLUMINESCENT METAL ION ASSAY Thompson, Richard B. (US) 2014-09-18 US claimed
EP-1583541-A2 COMPOUNDS AND METHODS FOR INCREASING NEUROGENESIS Neuronova AB (SE) 2005-10-12 EP claimed
US-20050009847-A1 Compounds and methods for increasing neurogenesis NEURONOVA AB (COMPANY REGISTRATION NO. 556703-0118) (SE) 2005-01-13 US claimed
WO-2004045592-A2 COMPOUNDS AND METHODS FOR INCREASING NEUROGENESIS NEURONOVA AB (SE) 2004-06-03 WO claimed
CN-1382699-A Polypeptide-nuclear triphosphoddenosine bindin-30.47 and polynucleotide for coding it BIOWINDOW GENE DEV INC (CN) 2002-12-04 CN claimed
EP-0344807-B1 Method for evaluating the permeability of a thin membrane HAMAMATSU PHOTONICS KK (JP) 1997-09-03 EP claimed
EP-0344807-A2 Method for evaluating the permeability of a thin membrane HAMAMATSU PHOTONICS K.K. (JP) 1989-12-06 EP claimed
US-4698387-A Allosteric conjugates of hemoglobin and use as blood substitutes INTERMEDICAT GMBH (CH) 1987-10-06 US claimed
EP-0145373-A2 Purification of cancer-associated protein and preparation of antibody thereto THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1985-06-19 EP claimed
WO-1985002467-A1 PURIFICATION OF CANCER-ASSOCIATED PROTEIN AND PREPARATION OF ANTIBODY THERETO THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1985-06-06 WO claimed
JP-4265859-A None JP disclosed
US-3954726-A Double salts of S-adenosil-L-methionine BIORESEARCH LIMITED (IT) 1976-05-04 US disclosed